Evidence map›Paper›PMID 29794057›Full record

ArticlemSphere

Genes Activated by

Cornelia List, Andreas Grutsch, Claudia Radler, Fatih Cakar, Franz G Zingl, Kristina Schild-Prüfert, Stefan Schild

Open access · goldAbstract read
In one paragraph

Article in mSphere. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Genomic analysis ofHeliyon · 2023
    Article
  3. Review
  4. Article
  5. Article
  6. Virulence, Resistance, and Genomic Fingerprint Traits ofMicrobial drug resistance (Larchmont, N.Y.) · 2020
    Article
  7. TetR RegulatedBio-protocol · 2020
    Article
  8. Article
  9. Environmental and Clinical Strains ofFrontiers in microbiology · 2019
    Article
  10. Article
  11. Regulated Proteolysis inFrontiers in cellular and infection microbiology · 2019
    Review
  12. The Interface ofGut microbes
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Cornelia ListInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Andreas GrutschInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Claudia RadlerInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Fatih CakarInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Franz G ZinglInstitute of Molecular Biosciences, University of Graz, Graz, Austria.
Kristina Schild-Prüfert *Institute of Molecular Biosciences, University of Graz, Graz, Austria kristina.schild@uni-graz.at stefan.schild@uni-graz.at.
Stefan Schild *Institute of Molecular Biosciences, University of Graz, Graz, Austria kristina.schild@uni-graz.at stefan.schild@uni-graz.at.
University of Graz · ATBioTechMed-Graz · AT

Funding

Enhancing and expanding the CGC Strain CollectionP40OD010440 · OD · UNIVERSITY OF MINNESOTA · PI Ann E. Rougvie · 2012 to 2026
$7.5M
Austrian Science Fund FWF P 27654NIH HHS P40 OD010440
6 · The paper itself

Abstract

During its life cycle, the facultative human pathogen

Indexed as

Bacterial AdhesionAnimalsCaenorhabditis elegansCholeraDisease Models, AnimalFimbriae ProteinsGene Expression ProfilingMannose-Binding LectinVibrio choleraeFimbriae ProteinsMannose-Binding LectinMshA protein, Vibrio choleraebacterial grazingbacterivorouschitindevelopmentenvironmentgrowth retardationMSHAnematodesnutritionpredator modelRIVETsurvival

Identifiers

PMID29794057
PMCPMC5967197
OpenAlexW2803696647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.